Project Grant K99EB037396
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
- The federal Project Grant award of $884,573 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is being used by Brigham & Women's Hospital Inc. to develop an "Abbreviated Yet Enhanced Neuro MRI Protocol." The project aims to reduce brain MRI exam duration by roughly three-fold while capturing quantitative and qualitative MRI contrasts as...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31,...
- This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an innovative magnetic resonance imaging (MRI) technology. The $391,875 award to The General Hospital Corporation, doing business as Massachusetts General Hospital, aims to address the flip angle inhomogeneity issue in high-field 7...
- The National Institute of Mental Health (NIMH) awarded a $156,656 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The General Hospital Corporation (doing business as Massachusetts General Hospital) to advance functional MRI (fMRI) techniques for mapping brain activity across cerebral cortical layers. The project aims to validate and benchmark a "linescan fMRI" method that can achieve higher spatial resolution than conventional laminar fMRI, enabling...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $459,264 Project Grant to The Johns Hopkins University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, which runs from Apr 8, 2025 to Feb 28, 2029, will support research and development to enhance resolution and contrast in magnetic resonance (MR) neuroimaging. This is intended to help standardize the appearance of MR neuroimages...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
- The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
- This federal Project Grant award of $422,623.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), supports the development of a high-fidelity brain perfusion MRI technique for newborns less than one week of age. The project, led by The Johns Hopkins University, aims to address the critical challenge of measuring cerebral blood flow...
This federal Project Grant award, titled "Fingerprinting Spatiotemporal Patterns of Brain Maturation with Combined Diffusion-Relaxometry Microstructure Imaging," is funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The $134,730 award, effective August 1, 2025, supports research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop novel magnetic resonance imaging (MRI) methods that can better differentiate between cellular changes associated with brain development, such as synaptic pruning and myelination. The goal is to provide a more detailed "fingerprint" of normal brain maturation that could enhance the understanding of neurodevelopmental disorders. The project will run for 2 years, with a final completion date of July 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $134.7k | 7/31/25 |